DOI: 10.14704/nq.2022.20.8.NQ44453
Cabergoline
Mohammed Rabie Osman Mahdy1*, AmgadOsman Gohar2,Hashem Fares Mohammed3,Alaa GamalAbd Al Azeem4, Mohamed Ahmed Ahmed5
Abstract
The syndrome nearly always presents either up to eight days once human chorionic gonadotrophin administration
in vulnerable patients (early onset) or throughout early physiological state, nine or additional days once human
chorionic gonadotrophin administration associated with physiological state evoked human chorionic gonadotrophin
production.
Keywords
Treating Modalities, Cavum and Lungs, Gonadotrophin Injection.
Full Text
PDF
References
